Small bowel bacterial overgrowth syndrome
Small bowel bacterial overgrowth syndrome
Small bowel bacterial overgrowth syndrome (SBBOS) is a disorder characterised by excessive amounts of bacteria in the small bowel resulting in gastrointestinal symptoms.
Last updated: 1
st
January 2025
Epidemiology
Incidence: 200.00 cases per 100,000 person-years
Peak incidence: 70+ years
Sex ratio: 1:1
<1
1-5
6+
16+
30+
40+
50+
60+
70+
80+
Aetiology
Risk factors for SBBOS
neonates with congenital gastrointestinal abnormalities
scleroderma
diabetes mellitus
Improve
Clinical features
It should be noted that many of the features overlap with irritable bowel syndrome:
chronic
diarrhoea
bloating
,
flatulence
abdominal pain
Improve
Investigations
Diagnosis
hydrogen breath test
small bowel aspiration and culture: this is used less often as invasive and results are often difficult to reproduce
clinicians may sometimes give a course of antibiotics as a diagnostic trial
Improve
Management
Management
correction of underlying disorder
antibiotic therapy: rifaximin is now the treatment of choice due to relatively low resistance. Co-amoxiclav or metronidazole are also effective in the majority of patients.
Improve
Gastroenterology
Small bowel bacterial overgrowth syndrome